Aurobindo Pharma gets USFDA nod for generic of Revatio drug

Aurobindo Pharma gets USFDA nod for generic of Revatio drug

The drug is used to treat pulmonary arterial hypertension and improve exercise capacity in adults

FPJ Web DeskUpdated: Thursday, December 29, 2022, 11:16 AM IST
article-image
Image credit: Wikipedia (Representative)

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.

The drug is a generic version of Viatris Inc's Revatio oral suspension.

It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.

RECENT STORIES

Lodha Developers To Launch ₹14k Cr Worth Housing Projects In 2nd Half Of FY26

Lodha Developers To Launch ₹14k Cr Worth Housing Projects In 2nd Half Of FY26

Gold Could Retest Record Highs As Traders Eye Powell's Speech, RBI Policy: Analysts

Gold Could Retest Record Highs As Traders Eye Powell's Speech, RBI Policy: Analysts

Udyogini Yojana: A Big Opportunity For Women Entrepreneurs, Find Out How You Can Get A Loan Up to...

Udyogini Yojana: A Big Opportunity For Women Entrepreneurs, Find Out How You Can Get A Loan Up to...

NSE, BSE Impose ₹5.42 Lakh Penalty On MTNL For Violating SEBI Board Composition Rules

NSE, BSE Impose ₹5.42 Lakh Penalty On MTNL For Violating SEBI Board Composition Rules

Netbanking 2.0 To Make Online Payments Faster, NPCI’s New ‘Banking Connect’ Brings QR Payments...

Netbanking 2.0 To Make Online Payments Faster, NPCI’s New ‘Banking Connect’ Brings QR Payments...